Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: NEM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on NEM, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 243,496 NEM shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 243,496 shares
    Change vs previous 13F 0 shares

    0.42% of the 13F portfolio, value $22,742,526.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 243,496 shares
    Change vs previous 13F -84,693 shares

    0.51% of the 13F portfolio, value $26,358,442.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 328,189 shares
    Change vs previous 13F -137,254 shares

    0.69% of the 13F portfolio, value $32,772,129.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 465,443 shares
    Change vs previous 13F +68,811 shares

    0.88% of the 13F portfolio, value $39,244,460.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 396,632 shares
    Change vs previous 13F -82,764 shares

    0.72% of the 13F portfolio, value $23,109,543.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 479,396 shares
    Change vs previous 13F +135,480 shares

    0.72% of the 13F portfolio, value $23,147,096.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 343,916 shares
    Change vs previous 13F -185,880 shares

    0.44% of the 13F portfolio, value $12,801,587.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 529,796 shares
    Change vs previous 13F not available

    0.98% of the 13F portfolio, value $28,319,637.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).